Codice QR

Pan cohort immune biomarker of CD8 lymphocyte activation enabling HGSOC outcome prediction and treatment response

Abstract Background High-grade serous ovarian cancer (HGSOC) exhibits poor prognosis due to late diagnosis, chemoresistance, and limited responses to immune checkpoint inhibitors. Although tumor‐infiltrating CD8+ T cells correlate with improved survival, current prognostic models remain inadequate....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Xinkui Liu, Zhen Zhang, Bin Wang, Liping Qin, Nannan Fan, Ruohan Wang, Xiaoyan Yu, Qiaoqiao Han, Zihan Lu, Siambi Kikete, Feifei Shi, Chu Chu, Yunhong Zhang, Liangzhong Niu, Ran Wei, Jiarui Wu, Xia Li
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer 2025-12-01
Serie:Discover Oncology
Soggetti:
Accesso online:https://doi.org/10.1007/s12672-025-04363-5
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!